The colon can absorb iron.We propose an integrated approach utilizing colonic transendoscopic enteral tubing to deliver iron in different valence states, coupled with washed microbiota transplantation . This clinical trial aims to assess the feasibility, safety, and efficacy of this approach for the treatment of iron deficiency.
ferritin ≤30 μg/L;
feasible colonic TET placement (cephalic end in the ileocecal region);
completion of 3 WMT sessions.
The patient has other co-morbidities that can lead to iron deficiency, such as acute gastrointestinal haemorrhage and menorrhagia.etc.
People who are allergic to iron or taking oral medications that interfere with iron absorption.
Patients with heart, brain, lung, liver, kidney and other serious diseases;
Patients do not cooperate to complete the clinical trial process;
Parallel
Ferrous Lactate
DrugThe injection solution was 3 ferrous lactate (10ml:0.1g iron) mixed with 20ml saline.
Iron sucrose
DrugThe injection was 3 shots of ferrous lactate (5ml:100mg iron) mixed with 35ml saline.
0.9% NaCl solution
DrugThe same volume and color as Iron sucrose.
Reticulocyte haemoglobin values in blood
To compare the level of reticulocyte haemoglobin in the blood before and after administration of iron lactate, iron sucrose and saline.
Serum ferritin levels
To compare the level of ferritin in the serum before and after administration of iron lactate, iron sucrose and saline.
Incidence of Treatment-Emergent Adverse Events
The number of adverse reactions that are associated with iron medicine reported by subjects from the start of treatment to the end of follow-up.
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
